2020
Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis
Risch HA. Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis. American Journal Of Epidemiology 2020, 189: 1218-1226. PMID: 32458969, PMCID: PMC7546206, DOI: 10.1093/aje/kwaa093.Peer-Reviewed Original ResearchConceptsOutpatient treatmentHigh-risk COVID-19 patientsSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2High-risk patientsUse of hydroxychloroquineMultiple comorbid conditionsCOVID-19 patientsEfficacy of hydroxychloroquineEarly outpatient treatmentStandard of careSyndrome coronavirus 2Mild effectivenessOutpatient diseasesOutpatient illnessOutpatient trialSuch patientsSymptomatic diseaseComorbid conditionsCoronavirus 2Hospitalized inpatientsClinical trialsCandidate medicationsHydroxychloroquine
2015
Erratum: The Risks of Thromboembolism Vs. Recurrent Gastrointestinal Bleeding After Interruption of Systemic Anticoagulation in Hospitalized Inpatients With Gastrointestinal Bleeding: A Prospective Study
Sengupta N, Feuerstein J, Patwardhan V, Tapper E, Ketwaroo G, Thaker A, Leffler D. Erratum: The Risks of Thromboembolism Vs. Recurrent Gastrointestinal Bleeding After Interruption of Systemic Anticoagulation in Hospitalized Inpatients With Gastrointestinal Bleeding: A Prospective Study. The American Journal Of Gastroenterology 2015, 110: 480-480. PMID: 25743723, DOI: 10.1038/ajg.2015.41.Peer-Reviewed Original Research
2014
The Risks of Thromboembolism Vs. Recurrent Gastrointestinal Bleeding after Interruption of Systemic Anticoagulation in Hospitalized Inpatients With Gastrointestinal Bleeding: A Prospective Study
Sengupta N, Feuerstein J, Patwardhan V, Tapper E, Ketwaroo G, Thaker A, Leffler D. The Risks of Thromboembolism Vs. Recurrent Gastrointestinal Bleeding after Interruption of Systemic Anticoagulation in Hospitalized Inpatients With Gastrointestinal Bleeding: A Prospective Study. The American Journal Of Gastroenterology 2014, 110: 328. PMID: 25512338, DOI: 10.1038/ajg.2014.398.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAnticoagulantsBenzimidazolesbeta-AlanineCohort StudiesDabigatranEnoxaparinFemaleGastrointestinal HemorrhageHeparinHumansIschemic Attack, TransientLongitudinal StudiesMaleMiddle AgedMorpholinesPatient ReadmissionProspective StudiesPulmonary EmbolismPyrazolesPyridonesRecurrenceRivaroxabanStrokeThiophenesThromboembolismVenous ThrombosisWarfarinWithholding TreatmentConceptsRecurrent gastrointestinal bleedingGastrointestinal bleedingSystemic anticoagulationAnticoagulation continuationThromboembolic eventsThrombotic eventsEtiology of GIBProspective observational cohort studyIntensive care unit careHospital transfusion requirementsMajor thrombotic episodesRisk of continuationObservational cohort studyRisk of thromboembolismCox proportional hazardsTransfusion requirementsCohort studyHospital dischargeUnit careConsecutive patientsHospital readmissionThrombotic episodesProspective studyHospitalized inpatientsFollowing outcomes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply